rethinkPeptides Search
Menu
Study breakdown

Migraine Peptides PACAP and CGRP Both Cause Nausea and Balance Problems in Mice

Animal StudyLow Moderate evidence
The takeaway

Systemic PACAP-38 disrupts motion-induced thermoregulation and balance in mice, with some sex-specific effects, paralleling known CGRP effects on vestibular function.

Sex-specific

PACAP-38 increased postural sway in female mice only, reflecting known migraine sex differences

What the researchers found

IP PACAP-38 significantly disrupted motion-induced thermoregulation (nausea proxy) in both sexes, increased postural sway in females, and caused balance deficits — comparable to known CGRP effects.

Why it matters

Understanding how PACAP affects vestibular function supports developing anti-PACAP therapies for migraine patients who experience significant nausea, dizziness, and balance problems.

The numbers in context

IP injection of PACAP-38 and CGRP in C57BL/6J mice; PACAP blunted tail vasodilation, increased postural sway (females), impaired balance beam; CGRP affected rotarod.

How the study worked

Preclinical study in C57BL/6J mice using IP injection of PACAP-38 and CGRP with motion-induced thermoregulation, center of pressure, rotarod, and balance beam behavioral assays.

Who was studied

C57BL/6J wildtype mice

What this study cannot tell us

Mouse model — vestibular and nausea responses may differ in humans; IP delivery may not reflect natural PACAP release patterns during migraine; behavioral proxies for nausea have inherent limitations.

How to read the evidence

Preclinical mouse study with well-characterized behavioral assays; translational relevance to human migraine supported by existing PACAP/CGRP biology.

When this study was published

Published in 2025, advancing the understanding of PACAP's role in migraine-associated vestibular dysfunction.

The bigger picture

As anti-CGRP therapies become established for migraine, PACAP represents the next frontier — this study provides preclinical evidence that PACAP-targeted treatments could address vestibular migraine symptoms that anti-CGRP drugs may not fully resolve.

Questions still open

  • Would anti-PACAP antibodies reduce vestibular migraine symptoms in human patients?
  • Why does PACAP-38 affect postural sway differently in male vs female mice?

Common questions

What is PACAP and how is it related to migraine?
PACAP (pituitary adenylate-cyclase-activating polypeptide) is a neuropeptide found in the brain that, like CGRP, is elevated during migraine attacks. This study shows it can cause nausea and balance problems, suggesting anti-PACAP drugs could help treat these debilitating migraine symptoms.
Why do migraines cause nausea and dizziness?
Neuropeptides like PACAP and CGRP released during migraine affect the vestibular (balance) system and thermoregulation pathways. This study shows that PACAP-38 disrupts these systems in mice, helping explain the nausea, dizziness, and balance problems many migraine patients experience.

Read the original research

Comparing the impact of systemic pituitary adenylate-cyclase-activating polypeptide (PACAP) and calcitonin gene-related peptide (CGRP) on motion-induced nausea and balance behaviors in mice.

PloS one, 20(11), e0334444

Citation

Rahman, Shafaqat M; Dweh, Abigail; Luebke, Anne E. (2025). Comparing the impact of systemic pituitary adenylate-cyclase-activating polypeptide (PACAP) and calcitonin gene-related peptide (CGRP) on motion-induced nausea and balance behaviors in mice.. PloS one, 20(11), e0334444. https://doi.org/10.1371/journal.pone.0334444